Evaluation of the performance of a lateral flow device for quantitative detection of anti-SARS-CoV-2 IgG

Introduction: The AbC-19™ lateral flow immunoassay (LFIA) performance was evaluated on plasma samples from a SARS-CoV-2 vaccination cohort, WHO international standards for anti-SARS-CoV-2 IgG (human), individuals ≥2 weeks from infection of RT-PCR confirmed SARS-CoV-2 genetic variants, as well as mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, J.S., Robertson, L.J., Price, R., Curry, G., Farnan, J., Black, A., Nesbit, M.A., McLaughlin, J.A., Moore, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472806/
https://www.ncbi.nlm.nih.gov/pubmed/38013966
http://dx.doi.org/10.1016/j.clicom.2022.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472806/
https://www.ncbi.nlm.nih.gov/pubmed/38013966
http://dx.doi.org/10.1016/j.clicom.2022.09.001

Ejemplares similares